Pfizer is committed to helping people with rheumatoid arthritis (RA) become empowered to play an important role in managing their medical condition. What does personal empowerment mean? It is a process that may help patients work with their medical team to act on medical and lifestyle issues that they, together, define as important. Empowerment means becoming a partner with the healthcare professional (HCP) team to participate in shared decision-making on personal treatment-related issues and options.
The following materials—created by Pfizer Medical Affairs—provide important content for adult patients who have RA.
Provide a refresher for adult patients on disease-related information that can be used to educate family members or friends about RA
Rheumatoid Arthritis: Disease Diagnosis and Management Materials
Patient empowerment begins with understanding how RA can be diagnosed and managed. These materials provide a helpful overview of RA, including disease characteristics and some types of therapies that may be used to manage it.
Read an overview of RA and the importance of taking your medicine as prescribed.
This in-depth instructional video provides detailed information on RA including common signs and symptoms, the underlying causes of RA, and disease management approaches.
Treat-to-Target (T2T) Patient Materials
Treat-to-Target (T2T) emphasizes the process of shared decision-making between patients and members of the medical team. Shared decision-making can only happen if parents are well informed about RA and their treatment options and communicate their expectations. The educational information on this site may help patients be better prepared to discuss their treatment choices, goals, and objectives with their HCP’s.
Read about the 4 T2T Principles and the 10 T2T Recommendations, which outline the goals of an RA treatment plan and the ways HCP’s measure RA disease activity.
MDHAQ Patient Materials
This guide helps patients understand how to use the MDHAQ (Multi-Dimensional Health Assessment Questionnaire to calculate their RAPID 3 (Routine Assessment of Patient Index Data 3) score by answering 2 lifestyle-related questions. The guide also instructs patients on how to work with their doctors to apply this score to track their RA disease activity over time.
This 2-page questionnaire allows patients to calculate their RAPID3 score, which may be used to assess their level of RA disease activity. Patients can write down their scores and bring the information to their next doctor’s appointment.
This resource lets you record your RAPID3 scores based on questions in the MDHAQ questionnaire in order to monitor your RA disease activity and identify important information for discussion with your healthcare professional.
RAPID3 Patient Materials
This guide helps patients learn how to use the RAPID3 (Route Assessment of Patient Index Data 3) form to calculate a RAPID3 score. The RAPID3 survey converts patients’ answers on how RA is affecting them into a numerical score that can be used to monitor RA disease activity over time.
Explore the RAPID3 self-assessment questionnaire and how to use it to calculate the RAPID3 score. This video provides step-by-step instructions on how to complete the RAPID3 Questionnaire, as well as how to record information for discussion with healthcare professionals.
This self-assessment questionnaire generates information to help calculate a RAPID3 score and provides an explanation of those numerical results. Patients can write down their scores and bring the information to their next doctor’s appointment.
This logbook enables you to record your RAPID3 scores, based on the RAPID3 questionnaire, to monitor your RA disease activity and identify important information for discussion with your healthcare professional.
Reproduction or distribution of this material is strictly prohibited without permission.
The RAPID3 system, and all copyright and trademark rights related thereto, is owned by Theodore Pincus and incorporated herein under license.
The health information in this site is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.
All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
This site is intended only for US residents.
2025 Pfizer Inc. All rights reserved.